Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diverse cutaneous manifestations associated with a single disease.

Literature DB >> 16333475

Diverse cutaneous manifestations associated with a single disease.

Jennifer Clay Cather¹, Estil A Vance, M Alan Menter.

Abstract

Year: 2002 PMID： 16333475 PMCID： PMC1276648 DOI： 10.1080/08998280.2002.11927876

Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN： 0899-8280

× No keyword cloud information.

36 in total

Review 1. Inflammatory skin diseases, T cells, and immune surveillance.

Authors: C Robert; T S Kupper
Journal: N Engl J Med Date: 1999-12-09 Impact factor: 91.245

2. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.

Authors: M A Weinstock; B Gardstein
Journal: Am J Public Health Date: 1999-08 Impact factor: 9.308

3. Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists.

Authors: J E Olerud; P A Kulin; D E Chew; R A Carlsen; S P Hammar; T W Weir; S D Patterson; J W Bolen; M E Kadin; E Barker
Journal: Arch Dermatol Date: 1992-04

4. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.

Authors: R Kurzrock; S Pilat; M Duvic
Journal: J Clin Oncol Date: 1999-10 Impact factor: 44.544

5. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

Authors: H H Roenigk; T M Kuzel; A P Skoutelis; E Springer; G Yu; W Caro; K Gilyon; D Variakojis; K Kaul; P A Bunn
Journal: J Invest Dermatol Date: 1990-12 Impact factor: 8.551

6. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.

Authors: B A Agnarsson; E C Vonderheid; M E Kadin
Journal: J Am Acad Dermatol Date: 1990-04 Impact factor: 11.527

7. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

Authors: F J Kaye; P A Bunn; S M Steinberg; J L Stocker; D C Ihde; A B Fischmann; E J Glatstein; G P Schechter; R M Phelps; F M Foss
Journal: N Engl J Med Date: 1989-12-28 Impact factor: 91.245

Diverse cutaneous manifestations associated with a single disease.

Review 1. Inflammatory skin diseases, T cells, and immune surveillance.

2. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.

3. Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists.

4. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.

5. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

6. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes.

7. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.

8. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients.

9. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

10. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.

Review 1. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.